This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of the Shiel Medical...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced its support for a lawsuit filed by the American Clinical Laboratory Association (ACLA)...
Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of Cleveland HeartLab. Quest will establish a national center of excellence focused on...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today provided an update on the impact of the Centers for Medicare and Medicaid Services (CMS)...
Bridgewater, N.J., and Secaucus, N.J., Nov. 13, 2017 -- Clinical Genomics, a private company and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services,...
Secaucus, NJ, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that it will present results of...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired certain assets of California Laboratory Associates (CLA), a clinical...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2017. "We...
Quest Diagnostics (NYSE: DGX) today announced it has formed a definitive agreement to acquire Cleveland HeartLab, a leader in innovative diagnostic services for managing cardiovascular disease,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired the outreach lab services operations of two hospitals of Hartford...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2017 results on Thursday, October 19, 2017,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will acquire the Shiel Medical Laboratory business...
More than 25 percent of patients monitored by lab tests for prescription drug adherence are concurrently taking both opioids and benzodiazepines, according to a new study published online today in...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the third quarter of 2017 it expects a reduction in revenues...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, responded today to the Centers for Medicare and Medicaid Services (CMS) publication of proposed 2018...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, was named for the thirteenth consecutive year in the North America Dow Jones Sustainability Index...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that all of the company's cholesterol test services that involve estimates of...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
A majority of test results of patients taking prescription medications show signs of drug misuse, including potentially dangerous drug combinations, finds a new large-scale analysis of laboratory...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2017 and raised...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of QHerit™, a new genetic screening service that provides women and men...
Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of the laboratory businesses Med Fusion and Clear Point. Operating from a nearly 200,000...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2017 results on Tuesday, July 25, 2017,...